Semler Scientific (NASDAQ:SMLR) Releases Earnings Results, Beats Estimates By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings results on Monday. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35, Zacks reports. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%. The company had revenue of $13.51 million for the quarter.

Semler Scientific Stock Up 25.1 %

NASDAQ SMLR traded up $7.52 during trading hours on Tuesday, hitting $37.49. 111,367 shares of the company were exchanged, compared to its average volume of 186,188. The stock has a market cap of $262.06 million, a PE ratio of 16.72 and a beta of 0.92. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $53.38. The stock has a 50-day moving average price of $25.92 and a 200 day moving average price of $28.63.

Insider Activity at Semler Scientific

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the business’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the transaction, the chief executive officer now directly owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 30.20% of the stock is currently owned by company insiders.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.